These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23333901)

  • 21. Cisplatin enhances the anticancer effect of beta-lapachone by upregulating NQO1.
    Terai K; Dong GZ; Oh ET; Park MT; Gu Y; Song CW; Park HJ
    Anticancer Drugs; 2009 Nov; 20(10):901-9. PubMed ID: 19738461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A dual responsive nitric oxide / β-lapachone co-delivery platform for redox imbalance-enhanced tumor therapy.
    Yang HZ; Chen JJ; Zhang L; Tian XL; Wang R; Pu L; Yu XQ; Zhang J
    Eur J Pharm Biopharm; 2024 Aug; 201():114348. PubMed ID: 38844097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibility of cancer cells to beta-lapachone is enhanced by ionizing radiation.
    Park HJ; Ahn KJ; Ahn SD; Choi E; Lee SW; Williams B; Kim EJ; Griffin R; Bey EA; Bornmann WG; Gao J; Park HJ; Boothman DA; Song CW
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):212-9. PubMed ID: 15629614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mu-calpain activation in beta-lapachone-mediated apoptosis.
    Tagliarino C; Pink JJ; Reinicke KE; Simmers SM; Wuerzberger-Davis SM; Boothman DA
    Cancer Biol Ther; 2003; 2(2):141-52. PubMed ID: 12750552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The NQO1 bioactivatable drug, β-lapachone, alters the redox state of NQO1+ pancreatic cancer cells, causing perturbation in central carbon metabolism.
    Silvers MA; Deja S; Singh N; Egnatchik RA; Sudderth J; Luo X; Beg MS; Burgess SC; DeBerardinis RJ; Boothman DA; Merritt ME
    J Biol Chem; 2017 Nov; 292(44):18203-18216. PubMed ID: 28916726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic enhancement of antitumor effect of β-Lapachone by photodynamic induction of quinone oxidoreductase (NQO1).
    Lamberti MJ; Vittar NB; da Silva Fde C; Ferreira VF; Rivarola VA
    Phytomedicine; 2013 Aug; 20(11):1007-12. PubMed ID: 23746950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of solubility and bioavailability of beta-lapachone using cyclodextrin inclusion complexes.
    Nasongkla N; Wiedmann AF; Bruening A; Beman M; Ray D; Bornmann WG; Boothman DA; Gao J
    Pharm Res; 2003 Oct; 20(10):1626-33. PubMed ID: 14620518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Following anticancer drug activity in cell lysates with DNA devices.
    Kahanda D; Singh N; Boothman DA; Slinker JD
    Biosens Bioelectron; 2018 Nov; 119():1-9. PubMed ID: 30098460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. STAT1 potentiates oxidative stress revealing a targetable vulnerability that increases phenformin efficacy in breast cancer.
    Totten SP; Im YK; Cepeda Cañedo E; Najyb O; Nguyen A; Hébert S; Ahn R; Lewis K; Lebeau B; La Selva R; Sabourin V; Martínez C; Savage P; Kuasne H; Avizonis D; Santos Martínez N; Chabot C; Aguilar-Mahecha A; Goulet ML; Dankner M; Witcher M; Petrecca K; Basik M; Pollak M; Topisirovic I; Lin R; Siegel PM; Kleinman CL; Park M; St-Pierre J; Ursini-Siegel J
    Nat Commun; 2021 Jun; 12(1):3299. PubMed ID: 34083537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitochondrial activity is the key to the protective effect of β-Lapachone, a NAD
    Lin SY; Syu JP; Lo YT; Chau YP; Don MJ; Shy HT; Lai SM; Kung HN
    Phytomedicine; 2022 Jul; 101():154094. PubMed ID: 35447421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. X-ray repair cross-complementing protein 1 (XRCC1) loss promotes β-lapachone -induced apoptosis in pancreatic cancer cells.
    Zheng Y; Zhang H; Guo Y; Chen Y; Chen H; Liu Y
    BMC Cancer; 2021 Nov; 21(1):1234. PubMed ID: 34789190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. beta-Lapachone-induced apoptosis in human prostate cancer cells: involvement of NQO1/xip3.
    Planchon SM; Pink JJ; Tagliarino C; Bornmann WG; Varnes ME; Boothman DA
    Exp Cell Res; 2001 Jul; 267(1):95-106. PubMed ID: 11412042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone.
    Bey EA; Bentle MS; Reinicke KE; Dong Y; Yang CR; Girard L; Minna JD; Bornmann WG; Gao J; Boothman DA
    Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11832-7. PubMed ID: 17609380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heat-induced up-regulation of NAD(P)H:quinone oxidoreductase potentiates anticancer effects of beta-lapachone.
    Park HJ; Choi EK; Choi J; Ahn KJ; Kim EJ; Ji IM; Kook YH; Ahn SD; Williams B; Griffin R; Boothman DA; Lee CK; Song CW
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8866-71. PubMed ID: 16361576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. β-lapachone significantly increases the effect of ionizing radiation to cause mitochondrial apoptosis via JNK activation in cancer cells.
    Park MT; Song MJ; Lee H; Oh ET; Choi BH; Jeong SY; Choi EK; Park HJ
    PLoS One; 2011; 6(10):e25976. PubMed ID: 21998736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly(ADP-ribose) Polymerase Inhibitors.
    Huang X; Motea EA; Moore ZR; Yao J; Dong Y; Chakrabarti G; Kilgore JA; Silvers MA; Patidar PL; Cholka A; Fattah F; Cha Y; Anderson GG; Kusko R; Peyton M; Yan J; Xie XJ; Sarode V; Williams NS; Minna JD; Beg M; Gerber DE; Bey EA; Boothman DA
    Cancer Cell; 2016 Dec; 30(6):940-952. PubMed ID: 27960087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperthermia enhances the effect of β-lapachone to cause γH2AX formations and cell death in human osteosarcoma cells.
    Hori T; Kondo T; Lee H; Song CW; Park HJ
    Int J Hyperthermia; 2011; 27(1):53-62. PubMed ID: 21070139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of beta-lapachone prodrugs for therapy against human cancer cells with elevated NAD(P)H:quinone oxidoreductase 1 levels.
    Reinicke KE; Bey EA; Bentle MS; Pink JJ; Ingalls ST; Hoppel CL; Misico RI; Arzac GM; Burton G; Bornmann WG; Sutton D; Gao J; Boothman DA
    Clin Cancer Res; 2005 Apr; 11(8):3055-64. PubMed ID: 15837761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NAD(P)H:Quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity.
    Pink JJ; Planchon SM; Tagliarino C; Varnes ME; Siegel D; Boothman DA
    J Biol Chem; 2000 Feb; 275(8):5416-24. PubMed ID: 10681517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic effects of radiation and beta-lapachone in DU-145 human prostate cancer cells in vitro.
    Suzuki M; Amano M; Choi J; Park HJ; Williams BW; Ono K; Song CW
    Radiat Res; 2006 May; 165(5):525-31. PubMed ID: 16669706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.